Axiom Investment Management LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1513703
NEW YORK, NY
Position in PTGX
as of Mar 31, 2026
· filed May 26, 2026
Position Value
$210,800
New position
Shares Held
2,000
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Axiom Investment Management LLC holds $731,842 across 12 Biotechnology names. PTGX ranks #2 (28.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
633 | $282,655 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
This page
|
2,000 | $210,800 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
1,000 | $58,150 | |
| 4 | MRNA |
Moderna, Inc.
|
1,066 | $54,152 | |
| 5 | PRQR |
ProQR Therapeutics N.V.
|
33,000 | $53,460 | |
| 6 | ARGX |
Argenx SE
|
69 | $50,385 | |
| 7 | IFRX |
InflaRx N.V.
|
10,000 | $8,940 | |
| 8 | SGMOQ |
Sangamo Therapeutics, Inc
|
25,375 | $6,342 |
All Filings in PTGX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $210,800 | 2,000 | Shares | Sole | 2026-05-26 | |
| No filing history on record for this holder in this stock. | ||||||